Thomas Scherzer

908 total citations
31 papers, 671 citations indexed

About

Thomas Scherzer is a scholar working on Epidemiology, Hepatology and Rheumatology. According to data from OpenAlex, Thomas Scherzer has authored 31 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Hepatology and 3 papers in Rheumatology. Recurrent topics in Thomas Scherzer's work include Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (12 papers). Thomas Scherzer is often cited by papers focused on Hepatitis C virus research (17 papers), Liver Disease Diagnosis and Treatment (14 papers) and Hepatitis B Virus Studies (12 papers). Thomas Scherzer collaborates with scholars based in Austria, United States and Philippines. Thomas Scherzer's co-authors include Péter Ferenci, Petra Steindl‐Munda, S. Beinhardt, Karoline Rutter, Albert Friedrich Stättermayer, Heribert Hofer, A Maieron, Christian Datz, Michael Straßer and Rudolf Stauber and has published in prestigious journals such as Blood, Gastroenterology and PLoS ONE.

In The Last Decade

Thomas Scherzer

31 papers receiving 653 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Scherzer Austria	14	468	421	119	88	60	31	671
Giorgio Fiore Italy	12	195 0.4×	192 0.5×	64 0.5×	23 0.3×	7 0.1×	40	439
Maria Paola Perrone Italy	10	114 0.2×	99 0.2×	125 1.1×	17 0.2×	32 0.5×	30	468
Noriyuki Obara Japan	12	219 0.5×	289 0.7×	46 0.4×	10 0.1×	9 0.1×	22	419
Romualdo Mazzi Italy	8	51 0.1×	128 0.3×	16 0.1×	38 0.4×	74 1.2×	16	316
Maria Lúcia Alves Pedroso Brazil	11	135 0.3×	175 0.4×	45 0.4×	6 0.1×	11 0.2×	22	296
Andrew Tran United States	11	195 0.4×	226 0.5×	13 0.1×	5 0.1×	15 0.3×	32	435
Debra Ogata-Arakaki United States	10	15 0.0×	240 0.6×	48 0.4×	37 0.4×	91 1.5×	13	437
Kornelija Suveizdytė United Kingdom	6	156 0.3×	234 0.6×	202 1.7×	4 0.0×	11 0.2×	6	474
Pattarawat Thantiworasit Thailand	10	37 0.1×	71 0.2×	70 0.6×	66 0.8×	24 0.4×	26	363
Bernadette DeArmond United States	7	10 0.0×	707 1.7×	77 0.6×	18 0.2×	65 1.1×	8	861

Countries citing papers authored by Thomas Scherzer

Since Specialization

Citations

This map shows the geographic impact of Thomas Scherzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Scherzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Scherzer more than expected).

Fields of papers citing papers by Thomas Scherzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Scherzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Scherzer. The network helps show where Thomas Scherzer may publish in the future.

Co-authorship network of co-authors of Thomas Scherzer

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Scherzer. A scholar is included among the top collaborators of Thomas Scherzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Scherzer. Thomas Scherzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pilger, Alexander, Helmuth Haslacher, Bernhard M. Meyer, et al.. (2018). Midday and nadir salivary cortisol appear superior to cortisol awakening response in burnout assessment and monitoring. Scientific Reports. 8(1). 9151–9151. 16 indexed citations

Haslacher, Helmuth, Franz Ratzinger, Thomas Perkmann, et al.. (2017). A combination of routine blood analytes predicts fitness decrement in elderly endurance athletes. PLoS ONE. 12(5). e0177174–e0177174. 5 indexed citations

Haslacher, Helmuth, Elisabeth Ponocny‐Seliger, Thomas Perkmann, et al.. (2016). Low Vitamin D Levels Do Not Predict Hyperglycemia in Elderly Endurance Athletes (but in Controls). PLoS ONE. 11(6). e0157695–e0157695. 9 indexed citations

Bauer, Martin, et al.. (2014). A double-blind, randomized clinical study to determine the efficacy of benzocaine 10% on histamine-induced pruritus and UVB-light induced slight sunburn pain. Journal of Dermatological Treatment. 26(4). 367–372. 13 indexed citations

Rutter, Karoline, Albert Friedrich Stättermayer, Péter Ferenci, et al.. (2013). 896 SUCCESSFUL HCV ERADICATION DUE TO ANTIVIRAL THERAPY IS ASSOCIATED WITH IMPROVED LONG TERM OUTCOME OF PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 58. S369–S369. 3 indexed citations

Stättermayer, Albert Friedrich, Robert Straßl, A Maieron, et al.. (2013). Polymorphisms of interferon-λ4andIL28B- effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 39(1). 104–111. 44 indexed citations

Rutter, Karoline, Heribert Hofer, S. Beinhardt, et al.. (2013). Durability of SVR in chronic hepatitis C patients treated with peginterferon‐α2a/ribavirin in combination with a direct‐acting anti‐viral. Alimentary Pharmacology & Therapeutics. 38(2). 118–123. 20 indexed citations

Payer, B.A., Thomas Reiberger, F Breitenecker, et al.. (2012). The risk of infections in HIV-HCV coinfected patients during antiviral therapy with pegIFN+RBV. Journal of Infection. 65(2). 142–149. 10 indexed citations

Drolz, Andreas, et al.. (2011). Extracorporeal artificial liver support in hypoxic liver injury. Liver International. 31(s3). 19–23. 10 indexed citations

10.

Beinhardt, S., Karoline Rutter, Judith Maresch, et al.. (2011). Treatment of Chronic Hepatitis C Genotype 1 Patients at An Academic Center in Europe Involved in Prospective, Controlled Trials. Hepatology. 55(1). 30–38. 14 indexed citations

11.

Beinhardt, S., Judith H. Aberle, Michael Straßer, et al.. (2011). Serum Level of IP-10 Increases Predictive Value of IL28B Polymorphisms for Spontaneous Clearance of Acute HCV Infection. Gastroenterology. 142(1). 78–85.e2. 78 indexed citations

12.

Quendler, Heribert, Norbert Kohrgruber, Georg Stingl, et al.. (2011). apoptosis in HIV-1 viremic patients T-cell + Plasmacytoid dendritic cells express TRAIL and induce CD4. 1 indexed citations

13.

Stauber, R.E., Thomas Scherzer, Csilla Putz‐Bankuti, et al.. (2011). 1186 BASELINE VITAMIN D LEVELS DO NOT INFLUENCE SVR IN PATIENTS WITH CHRONIC HCV GENOTYPE 1 OR 4 INFECTION UNDERGOING PEGINTERFERON/RIBAVIRIN TREATMENT. Journal of Hepatology. 54. S468–S469. 5 indexed citations

14.

Hofer, Heribert, Christian A. Mueller, Thomas Scherzer, et al.. (2010). Prevalence and clinical significance of GB virus type C/hepatitis G virus coinfection in patients with chronic hepatitis C undergoing antiviral therapy. Journal of Viral Hepatitis. 18(7). 513–517. 16 indexed citations

15.

Stättermayer, Albert Friedrich, Rudolf Stauber, Harald Hofer, et al.. (2010). Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C. Clinical Gastroenterology and Hepatology. 9(4). 344–350.e2. 144 indexed citations

16.

Stättermayer, Albert Friedrich, Karoline Rutter, S. Beinhardt, et al.. (2010). 1177 IMPACT OF IL28B-GENOTYPE ON TREATMENT OUTCOME OF AUSTRIAN PATIENTS WITH CHRONIC HEPATITIS C. Journal of Hepatology. 52. S455–S455. 2 indexed citations

17.

Stary, Georg, Irene Klein, Frieder Koszik, et al.. (2009). Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients. Blood. 114(18). 3854–3863. 89 indexed citations

18.

Scherzer, Thomas, Katharina Staufer, Gottfried Novacek, et al.. (2008). Efficacy and safety of antiviral therapy in patients with Crohn's disease and chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 28(6). 742–748. 22 indexed citations

19.

Scherzer, Thomas, K. Rajender Reddy, Fritz Wrba, et al.. (2008). Hepatocellular carcinoma in long‐term sustained virological responders following antiviral combination therapy for chronic hepatitis C. Journal of Viral Hepatitis. 15(9). 659–665. 17 indexed citations

20.

Zhang, Yan, Dongren Wang, Peter Lönnecke, Thomas Scherzer, & Michael R. Buchmeiser. (2006). Novel Initiators for Thermally and UV‐Triggered ROMP. Macromolecular Symposia. 236(1). 30–37. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact